Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Contract for for the Spot-IT Assay methodology as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot (NBS) in-service evaluation for Severe Combined Immuno-Deficiency (SCID) in 3 Screening laboratories.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| IMMUNOIVD AB | - | £700,000 | - |